Upstream Bio (UPB) Financials

Balance sheets

01 Sept 202401 June 202401 Dec 202301 Sept 2023

Total Assets

$232.7 M(-4.8%)$244.5 M(+108.6%)$117.2 M-

Current Assets

$227.3 M(-6.5%)$243.0 M(+107.7%)$117.0 M-

Non Current Assets

$5.4 M(+266.7%)$1.5 M(+632.7%)$202.0 K-

Total Liabilities

$393.0 M(+0.5%)$391.1 M(+62.8%)$240.3 M-

Current Liabilities

$10.9 M(+6.2%)$10.2 M(+57.2%)$6.5 M-

Long Term Liabilities

$382.1 M(+0.3%)$380.9 M(+62.9%)$233.8 M-

Shareholders Equity

-$160.3 M(-9.3%)-$146.6 M(-19.1%)-$123.1 M-

Book Value

-$160.3 M(-9.3%)-$146.6 M(-19.1%)-$123.1 M-

Working Capital

$216.4 M(-7.0%)$232.8 M(+110.7%)$110.5 M-

Cash And Cash Equivalents

$32.9 M(-30.4%)$47.3 M(+83.2%)$25.8 M-

Accounts Payable

$4.9 M(-11.9%)$5.6 M(+179.4%)$2.0 M-

Accounts Receivable

$607.0 K(+19.0%)$510.0 K(+420.4%)$98.0 K-

Short Term Debt

$678.0 K(+100.0%)$0.0(-100.0%)$45.0 K-

Long Term Debt

$1.3 M-$0.0-

Total Debt

$1.9 M(+100.0%)$0.0(-100.0%)$45.0 K(+100.0%)$0.0

Debt To Equity

0.0(0%)0.0(0%)0.0-

Current Ratio

20.9(-11.9%)23.7(+32.1%)18.0-

Quick Ratio

----

Inventory

----

Retained Earnings

-$169.5 M(-10.4%)-$153.5 M(-20.0%)-$128.0 M-

PB Ratio

----

Income statements

01 Sept 202401 June 202401 Dec 202301 Sept 2023

EPS

-$0.4--$0.4(-139.7%)-$0.2

TTM EPS

-$0.8--$0.6(-239.7%)-$0.2

Revenue

$607.0 K-$450.0 K(-27.5%)$621.0 K

TTM Revenue

$1.1 M-$1.1 M(+72.5%)$621.0 K

Total Expenses

$19.5 M-$14.8 M(+47.7%)$10.0 M

Operating Expenses

$19.5 M-$14.8 M(+47.7%)$10.0 M

Cost Of Goods Sold

----

TTM Cost Of Goods Sold

----

Gross Profit

----

TTM Gross Profit

----

Gross Margin

----

Operating Profit

-$18.9 M--$14.3 M(-52.7%)-$9.4 M

TTM Operating Profit

-$33.2 M--$23.7 M(-152.7%)-$9.4 M

Operating Margin

-3112.5%--3184.4%(-110.7%)-1511.4%

Net Income

-$16.0 M--$11.8 M(-281.5%)-$3.1 M

TTM Net Income

-$27.8 M--$14.9 M(-381.5%)-$3.1 M

Net Margin

-2634.6%--2629.6%(-426.4%)-499.5%

EBIT

-$18.9 M--$14.3 M(-52.7%)-$9.4 M

TTM EBIT

-$33.2 M--$23.7 M(-152.7%)-$9.4 M

EBITDA

-$18.9 M--$14.3 M(-52.8%)-$9.4 M

TTM EBITDA

-$33.2 M--$23.7 M(-152.8%)-$9.4 M

Selling, General & Administrative Expenses

$4.1 M-$3.2 M(+45.4%)$2.2 M

TTM SG&A

$7.3 M-$5.4 M(+145.4%)$2.2 M

Depreciation And Amortization

$40.0 K--$46.0 K

TTM D&A

$40.0 K--$46.0 K

Interest Expense

----

TTM Interest Expense

----

Income Tax

----

TTM Income Tax

----

PE Ratio

----

PS Ratio

----

Cashflow statements

01 Sept 202401 June 202401 Dec 202301 Sept 2023

Cash From Operations

-$39.6 M---$21.8 M

TTM CFO

-$39.6 M---$21.8 M

Cash From Investing

-$101.4 M---$77.6 M

TTM CFI

-$101.4 M---$77.6 M

Cash From Financing

$148.3 M--$129.7 M

TTM CFF

$148.3 M--$129.7 M

Free Cash Flow

-$39.9 M---$22.0 M

TTM FCF

-$39.9 M---$22.0 M

CAPEX

$326.0 K--$144.0 K

TTM CAPEX

$326.0 K--$144.0 K

Dividends Paid

----

TTM Dividends Paid

----

TTM Dividend Per Share

----

TTM Dividend Yield

----

Payout Ratio

----